Chong Kun Dang Pharmaceutical (185750) — Cash Flow Quality Index
Chong Kun Dang Pharmaceutical (185750) has a Cash Flow Quality Index of 0.96x as of March 2026. Operating cash flow of ₩12.32 Billion is below net income of ₩12.82 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Chong Kun Dang Pharmaceutical (185750) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Chong Kun Dang Pharmaceutical Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Chong Kun Dang Pharmaceutical across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 185750 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Chong Kun Dang Pharmaceutical (2016–2025)
Year-by-year earnings quality comparison for Chong Kun Dang Pharmaceutical. For live market cap and the full company financial profile, see how much is Chong Kun Dang Pharmaceutical worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.87x | ₩67.36 Billion | ₩77.51 Billion | ▲ +45.6% |
| 2024 | 0.60x | ₩64.29 Billion | ₩107.70 Billion | ▼ -60.8% |
| 2023 | 1.52x | ₩318.16 Billion | ₩208.86 Billion | ▲ +79.9% |
| 2022 | 0.85x | ₩67.73 Billion | ₩79.98 Billion | ▲ +158.7% |
| 2021 | 0.33x | ₩12.90 Billion | ₩39.42 Billion | ▼ -71.2% |
| 2020 | 1.14x | ₩104.32 Billion | ₩91.63 Billion | ▼ -20.6% |
| 2019 | 1.43x | ₩77.29 Billion | ₩53.88 Billion | ▲ +42.7% |
| 2018 | 1.01x | ₩42.63 Billion | ₩42.40 Billion | ▼ -33.8% |
| 2017 | 1.52x | ₩81.67 Billion | ₩53.81 Billion | ▲ +7.6% |
| 2016 | 1.41x | ₩57.79 Billion | ₩40.95 Billion | — |